Huadong Medicine Co Ltd
SZSE:000963
Huadong Medicine Co Ltd
SZSE:000963
Price:
33.25 CNY
-0.15%
Market Closed
Updated:
May 18, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
1.4
Current
1.8
Median
2.5
Industry
Lower
than median
Lower
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=1.4
Enterprise Value
/
57.5B
Revenue
40.9B
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.2B CNY | 1.4 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
73.4B USD | 0.2 | |
| US |
|
Cencora Inc
NYSE:COR
|
44.3B USD | 0.2 | |
| US |
|
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
24.2B USD | 0.1 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.6B USD | 0.9 | |
| KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.8 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
68.5B HKD | 0.1 | |
| IT |
|
Amplifon SpA
MIL:AMP
|
7.8B EUR | 3.8 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
52.6B CNY | 0.3 | |
| DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | 0.3 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
1.2
2-Years Forward
EV/S
1.1
3-Years Forward
EV/S
1
You don't have any saved screeners yet
